ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
University Medical Center Utrecht at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
University Medical Center Utrecht takes part in 23 sessions at ESMO 2026 in Madrid. Its program covers treatment outcomes and care decisions in melanoma and digestive cancers. It examines how neoadjuvant treatments compare in melanoma, alongside real-world outcomes and patient quality of life.
| Organization | ESMO 2026 Attendance |
|---|---|
University Medical Center Utrecht Utrecht, Netherlands | |
Academic hospital and faculty of medicine of Utrecht University, in the Netherlands. | Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Real-world outcomes of pembrolizumab in advanced deficient mismatch repair colorectal cancer Gastrointestinal cancers Poster Fri Oct 23 13:00–15:00 Trajectories of anxiety and depression symptoms in patients with gastroesophageal cancer: Results from a longitudinal Dutch cohort Gastrointestinal cancersNursing & supportive care Poster Fri Oct 23 15:15–16:00 Poster Fri Oct 23 15:15–16:00 Necrosis or malignant disease? Preoperative prediction of the histology of post-chemotherapy retroperitoneal residual masses in metastatic testicular germ cell tumors Genitourinary cancersSarcoma, CNS, head & neck and rare cancers Poster Fri Oct 23 15:15–16:00 Abstract Fri Oct 23 17:20–17:32 Invited Discussant 2072O and LBA55 Melanoma & skin cancers Chair Sat Oct 24 08:30–10:00 Talk Sat Oct 24 08:30–08:50 Chair Sat Oct 24 08:30–10:00 Closing the gap: Promising therapeutic modalities in colorectal cancer Gastrointestinal cancers Talk Sat Oct 24 08:45–09:00 Antibody Drug Conjugates (ADCs): Are we ready for prime time? Gastrointestinal cancers Chair Sat Oct 24 10:15–11:45 Rapid oral 1: Genitourinary tumours, renal and urothelial Genitourinary cancers Talk Sat Oct 24 10:35–10:55 Basic principles of theranostics Sarcoma, CNS, head & neck and rare cancers Abstract Sat Oct 24 11:00–11:15 Invited Discussant 4739RO, 4740RO and 4749RO Genitourinary cancers Poster Sat Oct 24 12:00–12:45 Poster Sat Oct 24 12:00–12:45 Association of emotional distress with immune checkpoint inhibitor outcomes in melanoma Melanoma & skin cancersNursing & supportive care Poster Sat Oct 24 12:00–12:45 Association of smoking with immune checkpoint inhibition outcomes in melanoma Melanoma & skin cancers Poster Sat Oct 24 12:00–12:45 Poster Sat Oct 24 12:00–12:45 Poster Sat Oct 24 12:00–12:45 Poster Sat Oct 24 12:00–12:45 Outcomes of combined percutaneous hepatic perfusion with ipilimumab plus nivolumab versus tebentafusp in liver-metastatic uveal melanoma Melanoma & skin cancersSarcoma, CNS, head & neck and rare cancers Poster Sat Oct 24 12:00–12:45 Post-diagnosis smoking and alcohol consumption in patients with gastroesophageal cancer and associations with survival and quality of life: A prospective cohort study Gastrointestinal cancersNursing & supportive care Poster Sat Oct 24 12:00–12:45 Chair Sat Oct 24 14:45–16:15 Cutting edge: The evolving role of surgeons in melanoma Melanoma & skin cancers Chair Sat Oct 24 14:45–15:30 Is HRD the next tumour-agnostic target in oncology? Biomarkers & precision oncology Talk Sat Oct 24 17:40–17:50 Poster Sun Oct 25 12:00–12:45 Abstract Mon Oct 26 09:08–09:18 Talk Mon Oct 26 09:30–09:40 CN71 - Nurses’ experiences with symptom management in oncological surgical practice Nursing & supportive care Poster Mon Oct 26 12:00–12:45 Talk Tue Oct 27 10:20–10:40 |
Find decision makers at University Medical Center Utrecht
Tell us what you sell and we’ll find the people at University Medical Center Utrecht most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction